Meningioma clinical trials at UC Irvine
2 in progress, 1 open to new patients
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
open to eligible people ages 18 years and up
This randomized phase III trial studies how well radiation therapy works compared with observation in treating patients with newly diagnosed grade II meningioma that has been completely removed by surgery. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors.
Orange, California and other locations
Vismodegib and FAK Inhibitor GSK2256098 in Treating Patients With Progressive Meningiomas
Sorry, currently not accepting new patients, but might later
This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningioma that is growing, spreading, or getting worse. Vismodegib and FAK inhibitor GSK2256098 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Orange, California and other locations
Last updated: